RU
Pulmonology
Ipratropium
Registration certificate:
LP-006476
INN:
Ipratropium Bromide
Release form:
Solution for inhalation
Therapeutic Area:
Pulmonology
Pharmacotherapeutic Group:
M-holinoblocker
Conditions for dispensing:
On prescription
Packaging:

Indications for Use:

  • Chronic Obstructive Pulmonary Disease (COPD)
  • Chronic Bronchitis
  • Pulmonary Emphysema
  • Bronchial Asthma (especially with concomitant cardiovascular conditions)

Included in the Essential Medicines List

Quality control
at all stages of production